MGRXMANGOCEUTICALS, INC.

Nasdaq www.mangorx.com


$ 0.39 $ 0.02 (6 %)    

Tuesday, 04-Jun-2024 15:58:05 EDT
QQQ $ 454.82 $ 1.24 (0.27 %)
DIA $ 398.57 $ 1.27 (0.33 %)
SPY $ 530.36 $ 0.59 (0.11 %)
TLT $ 91.26 $ 1.07 (1.17 %)
GLD $ 225.37 $ -1.95 (-0.9 %)
$ 0.371
$ 0.41
$ 0.00 x 0
$ 0.00 x 0
$ 0.34 - $ 0.41
$ 0.14 - $ 2.38
14,753,738
na
9.21M
$ -3.28
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 04-01-2024 12-31-2023 10-K
3 10-27-2023 09-30-2023 10-Q
4 07-28-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 mangorx-gets-patent-notice-of-allowance-in-japan-for-revolutionary-preventive-care-technology

Mangoceuticals, Inc. (NASDAQ:MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, an...

 mangorx-introduces-mojo-pharmaceutical-compounded-formula-featuring-enclomiphene-citrate-and-pregnenolone-for-treatment-of-low-testosterone-and-male-hormone-imbalances--sold-exclusively-on-mangorxs-website-on-a-subscription-basis-at-a-price-of-199-per-month

MOJO to be offered as an Oral Dissolvable Tablet (ODT) marketed to younger male demographic as an alternative to PRIME Testoste...

 mangoceuticals-develops-oral-glp-1s-stock-soars

Mangoceuticals announced the development of proprietary oral formulations of Semaglutide ("Slim") and Tirzepatide ("...

 mangoceuticals-q1-eps-010-up-from-023-yoy-sales-21409k-up-from-10072k-yoy

Mangoceuticals (NASDAQ:MGRX) reported quarterly losses of $(0.10) per share. This is a 56.52 percent increase over losses of $(...

 mangorx-acquires-patent-portfolio-for-total-of-20m-through-issuance-of-980k-of-6-series-c-convertible-preferred-shares

Mangoceuticals, Inc. (NASDAQ: MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, a...

 mangoceuticals-subsidiary-mangorx-mexico-executes-technical-agreement-with-mexican-pharmaceutical-manufacturer-for-initial-development-and-production-of-its-mango-erectile-dysfunction-products

Signifies the first major step towards the application process for the certification of itsMango ED oral dissolvable products b...

 why-salarius-pharmaceuticals-shares-are-trading-higher-by-around-31-here-are-20-stocks-moving-premarket

Shares of Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) rose sharply in today’s pre-market trading following fourth-quarter re...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION